Skip to main content
Other
Characterization of Immunological Reconstitution Following Alemtuzumab Therapy in Patients with Relapsing Remitting Multiple Sclerosis
(2009)
  • Stanley Krolczyk
  • Kelly L. Sullivan, Georgia Southern University
Disciplines
Publication Date
2009
Citation Information
Stanley Krolczyk (Principal Investigator) and Kelly L. Sullivan (Collaborator), "Characterization of Immunological Reconstitution Following Alemtuzumab Therapy in Patients with Relapsing Remitting Multiple Sclerosis," Genzyme Corporation. (2009-2012).